NATALIE SCHWER: Open Payments
NPI 1417472846 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 58 payments from 12 companies in 2025. Trend: 2023 $427 · 2024 $1,059 · 2025 $978
Food & beverage: $876Education: $101
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $200 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $180 |
| Otsuka America Pharmaceutical, Inc. | 9 | $164 |
| Teva Pharmaceuticals USA, Inc. | 5 | $155 |
| E.R. Squibb & Sons, L.L.C. | 4 | $70 |
| Alkermes, Inc. | 3 | $53 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Lundbeck LLC | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: CAPLYTA, SPRAVATO, REXULTI, COBENFY, ABILIFY ASIMTUFII, AUSTEDO XR, LYBALVI, Jornay PM.
Industry payments across PA — which companies pay providers there.
